As of close of business last night, Petros Pharmaceuticals Inc’s stock clocked out at $1.66, up 5.06% from its previous closing price of $1.58. In other words, the price has increased by $+0.0800 from its previous closing price. On the day, 940731 shares were traded.
Ratios:
To gain a deeper understanding of PTPI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 3.02. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTPI now has a Market Capitalization of 3.63M and an Enterprise Value of -5.65M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 0.51. Its current Enterprise Value per Revenue stands at -0.81 whereas that against EBITDA is 0.64.
Stock Price History:
Over the past 52 weeks, PTPI has reached a high of $9.54, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is 1.3532, while the 200-Day Moving Average is calculated to be 2.0825.
Shares Statistics:
It appears that PTPI traded 888.86K shares on average per day over the past three months and 1.46M shares per day over the past ten days. A total of 2.08M shares are outstanding, with a floating share count of 1.29M. Insiders hold about 41.45% of the company’s shares, while institutions hold 5.30% stake in the company. Shares short for PTPI as of Jan 31, 2024 were 242.4k with a Short Ratio of 0.27, compared to 41.69k on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 11.01% and a Short% of Float of 17.63%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$1.19, with high estimates of -$1.19 and low estimates of -$1.19.
Analysts are recommending an EPS of between -$5.15 and -$5.15 for the fiscal current year, implying an average EPS of -$5.15. EPS for the following year is -$5.01, with 1 analysts recommending between -$5.01 and -$5.01.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $6M in the next fiscal year. The high estimate is $6M and the low estimate is $6M. The average revenue growth estimate for next year is down -22.10% from the average revenue estimate for this year.
